Timing of once-a-day theophylline dose to match peak blood level with diurnal variation in severity of asthma

Abstract

To test the hypothesis that nighttime and early morning signs and symptoms of air flow obstruction in patients with moderately severe asthma would be better controlled by theophylline given on a once-a-day evening dosing schedule chosen to provide a peak blood level in the early morning than by the traditional twice-a-day dosing schedule designed to maintain levels more constant throughout the 24-hour period, the effects on nocturnal asthma of Uniphyl once a day and Theo-Dur twice a day were studied in 14 patients with moderately severe asthma. Although both regimens were effective, more patients preferred the Uniphyl dosing schedule. Nighttime symptoms were better controlled, without an increase in daytime symptoms or significant side effects. Optimal timing of theophylline dosing is an important consideration in the management of asthma.